These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2672556)

  • 1. Current models in pharmacokinetics: applications in veterinary pharmacology.
    Kinabo LD; McKellar QA
    Vet Res Commun; 1989; 13(2):141-57. PubMed ID: 2672556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mathematical modeling and simulation in animal health - Part II: principles, methods, applications, and value of physiologically based pharmacokinetic modeling in veterinary medicine and food safety assessment.
    Lin Z; Gehring R; Mochel JP; Lavé T; Riviere JE
    J Vet Pharmacol Ther; 2016 Oct; 39(5):421-38. PubMed ID: 27086878
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current and future directions of pharmacokinetic and pharmacokinetic-pharmacodynamic modelling and simulation: population approach group in Europe 19th annual meeting.
    Kloft C; Poggesi I
    Expert Opin Drug Metab Toxicol; 2010 Dec; 6(12):1599-604. PubMed ID: 20969486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics in veterinary medicine.
    Baggot JD
    Clin Pharmacokinet; 1992 Apr; 22(4):254-73. PubMed ID: 1606786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined pharmacokinetic/pharmacodynamic (PK/PD) modeling.
    Colburn WA
    J Clin Pharmacol; 1988 Sep; 28(9):769-71. PubMed ID: 3068258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of drug evaluation in children by population methods and modelling.
    Tod M; Jullien V; Pons G
    Clin Pharmacokinet; 2008; 47(4):231-43. PubMed ID: 18336053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mathematical modeling and simulation in animal health. Part I: Moving beyond pharmacokinetics.
    Riviere JE; Gabrielsson J; Fink M; Mochel J
    J Vet Pharmacol Ther; 2016 Jun; 39(3):213-23. PubMed ID: 26592724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity analysis of pharmacokinetic and pharmacodynamic systems: I. A structural approach to sensitivity analysis of physiologically based pharmacokinetic models.
    Nestorov IA
    J Pharmacokinet Biopharm; 1999 Dec; 27(6):577-96. PubMed ID: 11153447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Using the time of maximum effect site concentration to combine pharmacokinetics and pharmacodynamics.
    Minto CF; Schnider TW; Gregg KM; Henthorn TK; Shafer SL
    Anesthesiology; 2003 Aug; 99(2):324-33. PubMed ID: 12883405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed-loop stability of pharmacokinetic-pharmacodynamic models.
    Wada DR
    Math Biosci; 1997 Dec; 146(2):75-88. PubMed ID: 9348740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in veterinary clinical and fundamental pharmacology: past and future in The Netherlands.
    van Miert AS
    Vet Q; 2000 Jan; 22(1):3-11. PubMed ID: 10682380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic and pharmacodynamic data and models in clinical trials.
    Steimer JL; Ebelin ME; Van Bree J
    Eur J Drug Metab Pharmacokinet; 1993; 18(1):61-76. PubMed ID: 8335040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic/pharmacodynamic modeling: what it is!
    Colburn WA
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):545-55. PubMed ID: 3694497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Basic principles and techniques of pharmacokinetic modeling.
    Riviere JE
    J Zoo Wildl Med; 1997 Mar; 28(1):3-19. PubMed ID: 9226611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-pharmacokinetic/pharmacodynamic relationships.
    Mager DE
    Adv Drug Deliv Rev; 2006 Nov; 58(12-13):1326-56. PubMed ID: 17092600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methodological issues in pharmacokinetic-pharmacodynamic modelling.
    Bellissant E; Sébille V; Paintaud G
    Clin Pharmacokinet; 1998 Aug; 35(2):151-66. PubMed ID: 9739481
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expanding clinical applications of population pharmacodynamic modelling.
    Minto C; Schnider T
    Br J Clin Pharmacol; 1998 Oct; 46(4):321-33. PubMed ID: 9803979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maxsim2 - Real-time interactive simulations for computer-assisted teaching of pharmacokinetics and pharmacodynamics.
    Gabrielsson J; Andersson K; Tobin G; Ingvast-Larsson C; Jirstrand M
    Comput Methods Programs Biomed; 2014 Mar; 113(3):815-29. PubMed ID: 24461798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concepts and usefulness of pharmacokinetic-pharmacodynamic modelling.
    Holford NH
    Fundam Clin Pharmacol; 1990; 4 Suppl 2():93s-101s. PubMed ID: 2093643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the use of pharmacokinetic models.
    Rescigno A
    Phys Med Biol; 2004 Oct; 49(19):4657-76. PubMed ID: 15552423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.